Netherlands Diabetes Device Overview
In the Netherlands, 1.1 million persons (6.4% of the adult population) had diabetes in 2021. With 90% of cases, type 2 diabetes is the most prevalent condition in the Netherlands. 58,000 new cases of diabetes are reported annually in the Netherlands, where the disease is becoming more common. Individuals between the ages of 70 and 79 had increased prevalence rates of diabetes, ranging from 3.3% to 17.9%. Diabetes is one of the leading causes of illness and mortality in the Netherlands. Diabetes contributed to almost 12,000 fatalities in the country in 2019.Diabetes gadgets help patients manage their blood sugar levels more effectively and reduce their risk of problems such as renal disease, blindness, and amputations. With portable blood glucose meters, diabetics may monitor their blood glucose levels at home. They provide accurate and timely results so diabetics can make well-informed decisions regarding their medicine, diet, and exercise routine.
Diabetes devices can make managing the illness more flexible and easier and less disruptive to normal living. Insulin pumps are portable devices that pierce the skin to introduce a small tube that delivers insulin to the body. They provide a more flexible and accurate means of delivering insulin than traditional insulin injections, which can help diabetics better control their blood sugar levels.
Growth Drivers for the Netherlands Diabetes Device Market
The Netherlands' aging population is a major factor in the country's rising diabetes prevalence.In the Netherlands, an increasing number of people are developing diabetes, especially type 2, which is mostly caused by an aging population. Because of things like decreased insulin sensitivity and sedentary lifestyles, people are more likely to acquire diabetes as they get older. In order to treat the illness and avoid problems, this demographic shift calls for efficient monitoring technologies. The need for diabetes devices, like insulin delivery systems and continuous glucose monitoring, is rising as a result. Both patients and healthcare practitioners acknowledge the value of these technologies in optimizing quality of life, promoting proactive healthcare practices catered to older persons, and improving disease management.
Diabetes care is changing as a result of the Netherlands' rising need for remote monitoring systems.
Diabetes care is changing in the Netherlands due to the increasing need for remote monitoring options, especially with the growth of telehealth. Patients gain from improved access to healthcare providers without the requirement for in-person visits as healthcare increasingly moves toward virtual platforms. For people who are managing long-term diseases like diabetes, where regular monitoring is essential, this trend is especially significant. Patients can take proactive control of their condition with the help of remote monitoring technologies, like continuous glucose monitors and mobile health applications, which allow for real-time data tracking. Furthermore, by enabling prompt interventions by medical personnel, these solutions enhance overall patient outcomes. Diabetes devices are anticipated to be adopted at a higher rate as patients and clinicians adopt technology, making remote monitoring a major factor in the market's expansion.
Netherlands Diabetes Device Company Analysis
The major participants in the Netherlands Diabetes Device market includes Dexcom Inc, Medtronic, Roche, Abbott Laboratories, Eli Lilly, Terumo Corporation, BD.Netherlands Diabetes Device Company News
In February 2024, In Europe, Dexcom introduced their real-time CGM solution, Dexcom ONE+. A customizable continuous glucose monitoring device, Dexcom ONE+ can be worn at three separate body locations.In 2023, Roche Unveils Accu-Chek® Guide System. The Accu-Chek® Guide system has been introduced in the Dutch market by Roche, a prominent player in diabetes care. Patients with diabetes will find it easier to measure blood glucose with this system than with earlier models.
Types - Industry is divided into 4 viewpoints:
1. Self-Monitoring Devices2. Continuous Glucose-Monitoring Devices
3. Insulin Pumps
4. Insulin Pens
End User - Industry is divided into 3 viewpoints:
1. Hospitals2. Diagnostics Centers
3. Homecare
All companies have been covered with 5 Viewpoints
1. Overviews2. Key Person
3. Recent Developments & Strategies
4. Product Portfolio & Product Launch in Last 1 Year
5. Revenue
Company Analysis
1. Dexcom Inc2. Medtronic
3. Roche
4. Abbott Laboratories
5. Eli Lilly
6. Terumo Corporation
7. BD
Key Questions Answered in Report:
1. How big is the Netherlands Diabetes Device industry?2. What is the Netherlands Diabetes Device industry growth rate?
3. Who are the key players in Netherlands Diabetes Device industry?
4. What are the factors driving the Netherlands Diabetes Device industry?
5. Which Region held the largest market share in the Netherlands Diabetes Device industry?
6. What segments are covered in the Netherlands Diabetes Device Market report?
Table of Contents
Companies Mentioned
- Dexcom Inc
- Medtronic
- Roche
- Abbott Laboratories
- Eli Lilly
- Terumo Corporation
- BD
Methodology
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | October 2024 |
| Forecast Period | 2023 - 2032 |
| Estimated Market Value ( USD | $ 343.4 Million |
| Forecasted Market Value ( USD | $ 641.7 Million |
| Compound Annual Growth Rate | 7.1% |
| Regions Covered | Netherlands |
| No. of Companies Mentioned | 7 |
